Yi-Wah Chan

Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma

G. Abou-Alfa, R. Kelley, A. El-Khoueiry, 2021, Liver Cancer.